DentalCare Logo

Infection Control-Related Administrative Policies and Work Restrictions

Course Number: 473

PDF

References / Additional Resources

  1. Centers for Disease Control and Prevention. Guidelines for Infection Control in Dental Health-Care Settings. 2003. MMWR 2003;52(No. RR-17):1-76.

  2. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee, 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Am J Infect Control 2007;35:S65-164.

  3. Henderson DK, Dembry L, Fishman NO, et al. SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus. Infection control and hospital epidemiology, 2010 Mar; 31(3): 203-32.

  4. Sussman GL, Beezhold DH, Kurup VP. Allergens and natural rubber proteins. J Allergy Clin Immunol 2002;110(2 Suppl):S33-S39.

  5. Ahmed SM, Aw TC, Adisesh A. Toxicological and immunological aspects of occupational latex allergy. Toxicol Rev. 2004;23(2):123-34. doi: 10.2165/00139709-200423020-00005. PMID: 15578865.

  6. Allergen Nomenclature Sub-Committee. Allergen Nomenclature. Accessed April 8, 2021.

  7. Critchley E, Pemberton MN. Latex and synthetic rubber glove usage in UK general dental practice: changing trends. Heliyon. 2020 May 5;6(5):e03889. doi: 10.1016/j.heliyon.2020.e03889. PMID: 32405551; PMCID: PMC7210590.

  8. Ahmed DD, Sobczak SC, Yunginger JW. Occupational allergies caused by latex. Immunology Allergy Clin North Am 2003;23:205-19.

  9. Spina A, Levine H. Latex allergy: A review for the dental professional. Oral Surg Oral Med Oral Pathol Oral Rad Endod 1999;87:5-11.

  10. Farrell AL, Warshaw EM, Zhao Y, et al. Prevalence and methodology of evaluation for latex allergy among allergists in the United States: results of a cross-sectional survey. Am J Contact Dermat 2002;13:183-189.

  11. Hamann CP, Turjanmaa K, Rietschel R, et al. Natural rubber latex hypersensitivity. Incidence and prevalence of type I allergy in the dental professional. J Am Dent Assoc 1998;129:43-54.

  12. Hamann CP, Rodgers PA, Sullivan KM. Allergic contact dermatitis in dental professionals. Effective diagnosis and treatment. J Am Dent Assoc 2003;134:185-194.

  13. Taylor JS, Erkek E. Latex allergy: diagnosis and management. Dermatol Ther 2004;17:289-301.

  14. Schmid K, Cristoph BH, Niklas D, et al. Latex sensitization in dental students using powder-free gloves low in latex protein: a cross sectional study. Contact Dermatitis 2002;47:103-108.

  15. Bousquet J, Flahault A, Vandenplas O, et al. Natural rubber latex allergy among health care workers: a systematic review of the evidence. J Allergy Clin Immunol 2006;118:447-454.

  16. Larese Filon F, Bosco A, Fiorito A, Negro C, Barbina P. Latex symptoms and sensitization in health care workers. Int Arch Occup Environ Health. 2001 Apr;74(3):219-223.

  17. Lieberman P, Nicklas RA, Oppenheimer J,et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol. 2010 Sep;126(3):477-80.e1-42.

  18. Antezana M, Parker F. Occupational contact dermatitis. Immunol Allergy Clin North Am 2003;23:269-290.

  19. Hamilton RG. Diagnosis of natural rubber latex allergy. Methods 2002;23:22-31.

  20. Hamilton RG, Peterson EL, Ownby DR. Clinical and laboratory-based methods in the diagnosis of natural rubber latex allergy. J Allergy Clin Immunol 2002;110(2 Suppl):S47-S56.

  21. Charous BL, Tarlo SM, Charous MA, et al. Natural rubber latex allergy in the occupational setting. Methods 2002;27:15-21.

  22. Fish JE. Occupational asthma and rhinoconjunctivitis induced by natural rubber latex exposure. J Allergy Clin Immunol 2002;110(2 Suppl):S75-S81.

  23. Fish JE. Occupational asthma and rhinoconjunctivitis induced by natural rubber latex exposure. J Allergy Clin Immunol 2002;110(2 Suppl):S75-S81.

  24. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States. An investigation into its epidemiology. Arch Intern Med 2001;161:15-21.

  25. Lieberman P. Anaphylactic reactions during surgical and medical procedures. J Allergy Clin Immunol 2002;110(2 Suppl):S64-S9.

  26. Porri F, Lemiere C, Birnbaum J, et al. Prevalence of latex sensitization in subjects attending health screening: implications for a perioperative screening. Clin Exp Allergy. 1997 Apr;27(4):413-417.

  27. Pumphrey RSH, Duddridge M, Norton J. Fatal latex allergy. J Allergy Clin Immunology 2001;107:558.

  28. Fisher AA. Contact urticaria and anaphylactoid reactions to corn starch surgical glove powder. Contact Dermatitis 1987;16:224-225.

  29. Wakelin SH, White IR. Natural rubber latex allergy. Clin Exp Dermatol. 1999 Jul;24(4):245-248.

  30. Nettis E, Assennato G, Ferrannini A, et al. Type I allergy to natural rubber latex and type IV allergy to rubber chemical in healthcare workers with glove-related skin problems. Clin Exp Allergy 2002;32:441-447.

  31. Nettis E, Assennato G, Ferrannini A, et al. Type I allergy to natural rubber latex and type IV allergy to rubber chemical in healthcare workers with glove-related skin problems. Clin Exp Allergy 2002;32:441-447.

  32. Sicherer SH. Clinical implications of cross-reactive food allergens. J Allergy Clin Immunol 2001;108:881-890.

  33. Pereira C, Tavares B, Loureiro G, et al. Turnip and zucchini: new foods in the latex-fruit syndrome. Allergy. 2007 Apr;62(4):452-3. doi: 10.1111/j.1398-9995.2006.01313.x. PMID: 17362260.

  34. Hamilton RG, Adkinson NF Jr. Diagnosis of natural rubber latex allergy: multicenter latex skin testing efficacy study. Multicenter Latex Skin Testing Study Task Force. J Allergy Clin Immunol. 1998 Sep;102(3):482-490.

  35. Sanchez-Monge R, Blanco C, Lopez-Torrejon G, et al. Differential allergen sensitization patterns in chestnut allergy with or without associated latex-fruit syndrome. J Allergy Clin Immunol 2006;118:705-s10.

  36. T.R.U.E. test package insert. Accessed April 8, 2021.

  37. Baur X, Chen Z, Allmers H. Can a threshold limit value for natural rubber latex airborne allergens be defined? J Allergy Clin Immuno 1998;101(1 Part 1):24-27.

  38. Bernstein DI, Management of natural rubber latex allergy. J Allergy Clin Immunol 2002;110(2 Suppl):S111-S116.

  39. Centers for Disease Control and Prevention. National Institute of Occupational Safety and Health. Preventing allergic reactions to natural rubber latex in the workplace. Accessed April 8, 2021.

  40. Phillips V, Goodrich M, TJ S. Health Care Worker Disability Due to Latex Allergy and Asthma: A Cost Analysis. Am J Public Health 1999;89:1024-1028.

  41. Tarlo SM, Easty A, Eubanks K, et al. Outcomes of a natural rubber latex control program in an Ontario teaching hospital. J Allergy Clin Immunol 2001;108(4):628-633.

  42. Yunginger JW. Latex-associated anaphylaxis. Immunol Allergy Clin North Am 2001;21:669-677.

  43. Smith AM, Amin HS, Biagini RE, et al. Percutaneous reactivity to natural rubber latex proteins persist in health-care workers following avoidance of natural rubber latex. Clin Exp Allergy 2007;37:1349-1356.

  44. Drugs allergic disorders. Med Lett Drugs. Ther. 201 May;59(1520):71-80.

  45. Drugs for asthma and COPD. Treat Guidel Med Lett. 2013 Aug;11(132):75-86.

  46. An epinephrine prefilled syringe (Symjepi) for anaphylaxis. Med Lett Drugs Ther. 2019 Feb 25;61(1566):25-26. Corrected and republished in: JAMA. 2019 Apr 2;321(13):1306-1307.

  47. Centers for Disease Control and Prevention. About Measles. Accessed April 8, 2021.

  48. Centers for Disease Control and Prevention. About Mumps. Accessed April 8, 2021.

  49. Centers for Disease Control and Prevention. About Rubella. Accessed April 8, 2021.

  50. Centers for Disease Control and Prevention. Guidance for Dental Settings: Interim Infection Prevention and Control Guidance for Dental Settings During the COVID-19 Response. Accessed April 8, 2021.

  51. Centers for Disease Control and Prevention. Interim U.S. Guidance for Risk Assessment and Work Restrictions for Healthcare Personnel with Potential Exposure to SARS-CoV-2. Accessed April 8, 2021.

  52. Centers for Disease Control and Prevention. Return to Work Criteria for Healthcare Personnel with SARS-CoV-2 Infection (Interim Guidance). Accessed April 8, 2021.

  53. Centers for Disease Control and Prevention. About Chickenpox. Accessed April 8, 2021.

  54. Centers for Disease Control and Prevention. About Shingles (Herpes Zoster). Accessed April 8, 2021.

  55. Centers for Disease Control and Prevention. Influenza (Flu). Information for Health Professionals. Accessed April 8, 2021.

  56. Centers for Disease Control and Prevention. Pneumococcal Disease. Accessed April 8, 2021.

  57. Centers for Disease Control and Prevention. Meningococcal Disease. Accessed April 8, 2021.

  58. Centers for Disease Control and Prevention. Tuberculosis (TB). Accessed April 8, 2021.

  59. Centers for Disease Control and Prevention. Hepatitis A FAQs for Health Professionals. Accessed April 8, 2021.

Additional Resources


  • No Additional Resources Available
0/15Next